Clinical trials
Active, not recruiting Phase 1/2 Lung Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| Eli Lilly and Company | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Black Diamond Therapeutics, Inc. | 1 |
| Daiichi Sankyo | 1 |
| Grey Wolf Therapeutics | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 24 |
| Carcinoma, Non-Small-Cell Lung | 16 |
| Neoplasms | 6 |
| Breast Neoplasms | 4 |
| Head and Neck Neoplasms | 3 |
| Bronchial Neoplasms | 2 |
| Carcinoma, Bronchogenic | 2 |
| Carcinoma, Medullary | 2 |
| Central Nervous System Neoplasms | 2 |
| Colonic Neoplasms | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.